Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.

about

Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade.Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.

P2860

Q50063138-D1F7C315-99F8-44C0-9DB8-8BDE157C741A Q55154455-92D8918C-D767-4C4F-BCAE-11E40AC6B3B6

P2860

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.

Item

http://www.wikidata.org/entity/Q48127001

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Bullous pemphigoid associated ...... itors: A report of five cases.

@en

Bullous pemphigoid associated ...... itors: A report of five cases.

@nl

type

Item

label

Bullous pemphigoid associated ...... itors: A report of five cases.

@en

Bullous pemphigoid associated ...... itors: A report of five cases.

@nl

prefLabel

Bullous pemphigoid associated ...... itors: A report of five cases.

@en

Bullous pemphigoid associated ...... itors: A report of five cases.

@nl

P1476

Bullous pemphigoid associated ...... itors: A report of five cases.

@en

P2093

Kentaro Doi

http://www.w3.org/2001/XMLSchema#string

Masahito Ogura

http://www.w3.org/2001/XMLSchema#string

Rie Ko

http://www.w3.org/2001/XMLSchema#string

Riko Kashima

http://www.w3.org/2001/XMLSchema#string

Satoshi Yoshiji

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Harashima

http://www.w3.org/2001/XMLSchema#string

Takaaki Murakami

http://www.w3.org/2001/XMLSchema#string

P2860

Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors.

Screening Tool for Older Persons' Appropriate Prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on "Guidelines for medical treatment and its safety in the elderly".

Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.

Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database.

Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180.

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid.

P304

445-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1111/JDI.12695

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nobuya Inagaki

Daisuke Yabe

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28520234

http://www.w3.org/2001/XMLSchema#string

P932

5835473

http://www.w3.org/2001/XMLSchema#string

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.

about

P2860

P2860

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932